604 followers
21,388 followers
ESPOIR cohort with 172 early seronegative #RA patients finds that early csDMARD use (within 3 mos of Sx) was more likely to predict better outcomes that other prognostic risk (clinical lab or imaging) factors https://t.co/76J93mZ2NH
848 followers
Predictors of good response to csDMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort (via #pubmedontap) https://t.co/zHXQa5FTJF